Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

802
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
802
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.5K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.5K
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

1.4K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.4K
Types of Toxins01:36

Types of Toxins

3.0K
Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
3.0K
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

1.9K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.9K
Neural Regulation01:37

Neural Regulation

42.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
42.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Donald D. Brown (1931-2023).

Science (New York, N.Y.)·2023
Same author

Toxin Induced Parkinsonism and Hospitalization Related Adverse Outcome Mitigation for Parkinson's Disease: A Comprehensive Review.

Journal of clinical medicine·2023
Same author

Impact of botulinum toxin injection into the masticatory muscles on mandibular bone: A systematic review.

Journal of oral rehabilitation·2022
Same author

Improving access to care for patients with migraine in a remote Pacific population.

Neurology. Clinical practice·2020
Same author

Deep Brain Stimulation in a Case of Mitochondrial Disease.

Movement disorders clinical practice·2019
Same author

Distribution and Quantity of Sites of John Cunningham Virus Persistence in Immunologically Healthy Patients: Correlation With John Cunningham Virus Antibody and Urine John Cunningham Virus DNA.

JAMA neurology·2017
Same journal

Sports Neurology.

Neurologic clinics·2026
Same journal

Sports-Related Peripheral Nerve Injuries.

Neurologic clinics·2026
Same journal

Active Rehabilitation and Return to Play in Sports-Related Concussion.

Neurologic clinics·2026
Same journal

Autonomic Assessment and Management in Sports-Related Concussion.

Neurologic clinics·2026
Same journal

Management of Vestibular Symptoms in Sports-Related Concussion.

Neurologic clinics·2026
Same journal

Neuropsychological Assessment in Sport-Related Concussion: Evidence, Controversies, and Clinical Applications.

Neurologic clinics·2026
See all related articles

Related Experiment Video

Updated: Dec 6, 2025

The 6-hydroxydopamine Rat Model of Parkinson's Disease
08:10

The 6-hydroxydopamine Rat Model of Parkinson's Disease

Published on: October 27, 2021

12.2K

Toxin-Induced Parkinsonism.

Steven McKnight1, Nawaz Hack2

  • 1Neurology Department, Walter Reed National Military Medical Center, America Building #19, 6th Floor, Room 6146, 4954 North Palmer Road, Bethesda, MD 20889-5630, USA; Department of Defense, Walter Reed National Military Medical Center, America Building #19, 6th Floor, Room 6146, 4954 North Palmer Road, Bethesda, MD 20889-5630, USA.

Neurologic Clinics
|October 12, 2020
PubMed
Summary
This summary is machine-generated.

Environmental toxins like heavy metals and pesticides are linked to Parkinson disease risk. Exposure can cause oxidative stress, damaging crucial brain cells and leading to parkinsonism with varied treatment responses.

Keywords:
Agent orangeMPTPManganeseMercuryParaquatParkinsonismRotenone

More Related Videos

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

7.8K
Applying the RatWalker System for Gait Analysis in a Genetic Rat Model of Parkinson's Disease
04:08

Applying the RatWalker System for Gait Analysis in a Genetic Rat Model of Parkinson's Disease

Published on: January 18, 2021

3.2K

Related Experiment Videos

Last Updated: Dec 6, 2025

The 6-hydroxydopamine Rat Model of Parkinson's Disease
08:10

The 6-hydroxydopamine Rat Model of Parkinson's Disease

Published on: October 27, 2021

12.2K
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

7.8K
Applying the RatWalker System for Gait Analysis in a Genetic Rat Model of Parkinson's Disease
04:08

Applying the RatWalker System for Gait Analysis in a Genetic Rat Model of Parkinson's Disease

Published on: January 18, 2021

3.2K

Area of Science:

  • Neuroscience
  • Environmental Health
  • Toxicology

Background:

  • Idiopathic Parkinson disease (IPD) risk is associated with various environmental toxins.
  • These toxins include heavy metals, pesticides, and synthetic drug contaminants.
  • Some toxins induce oxidative stress, selectively damaging dopaminergic neurons in the central nervous system.

Purpose of the Study:

  • To review toxins linked to parkinsonism and IPD risk.
  • To discuss the neurotoxic mechanisms, particularly oxidative stress.
  • To examine the variable responses of toxin-induced parkinsonism to dopaminergic therapies.

Main Methods:

  • Literature review of toxins associated with parkinsonism.
  • Analysis of neurotoxic pathways, focusing on dopaminergic neuron damage.
  • Discussion of clinical presentations and therapeutic responses.

Main Results:

  • Several toxins, including manganese, mercury, MPTP, organochlorines, organophosphates, paraquat, rotenone, and Agent Orange, are discussed.
  • These agents can cause parkinsonism through mechanisms involving oxidative stress.
  • The clinical manifestations and treatment outcomes for toxin-induced parkinsonism vary.

Conclusions:

  • Environmental toxins represent a significant risk factor for Parkinson disease.
  • Understanding the specific mechanisms of these toxins is crucial for prevention and treatment.
  • Further research is ongoing for some toxins with less established links to IPD.